Stay updated on Phase 1b Micellar Docetaxel in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:27:00.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the clinical trial information regarding a new micellar Docetaxel compound for patients with metastatic castration-resistant prostate cancer. This change reflects advancements in developing steroid-free taxane regimens to improve safety profiles and avoid the need for steroid administration pre and post infusion.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:18.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, such as general health conditions and prior treatments, along with specific inclusion and exclusion criteria for the clinical trial. Previously, this section only indicated that no information was provided.
    Difference
    35%
    Check dated 2024-05-22T21:10:05.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:46:57.000Z thumbnail image

Stay in the know with updates to Phase 1b Micellar Docetaxel in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.